Featured Articles

  1. Best Practices For Evaluating Immunologically Active Compounds 10/9/2025

    Gain insight into the evolving landscape of immune-based drug development and best practices CROs should adopt to overcome its unique challenges.

  2. Early Immune Profiling With In Vivo, In Vitro, And Ex Vivo Systems 10/7/2025

    Modern biologics increasingly interact with the immune system. While these innovations enable transformative therapies, they can also provoke acute immune activation during first-in-human (FIH) trials.

  3. What Do Cancer Patients Really Want From mHealth Technology? 9/30/2025

    The success of mobile health (mHealth) tools depends on whether patients want to use them. Patient perspectives can guide design to reduce burden, build trust, and make digital tools truly meaningful.

  4. Rethinking Recruitment: Patient-Centric Strategies For The Future Of Clinical Trials 9/30/2025

    For sponsors and CROs, the message is clear: recruitment must be redesigned for accessibility, inclusivity, and patient trust.

  5. Navigating Adverse Immunostimulation: A Practical Guide For Clinical Researchers 9/30/2025

    Explore a systematic approach to evaluate adverse immunostimulation (AIS) in drug development through standardized biomarker sampling and tailored management strategies.

  6. Leveraging Biomarkers In Early PK/PD Studies 7/9/2025

    Integrating biomarkers into early clinical studies is crucial to determine whether a new therapy engages its biological target, triggers the intended PD effects, and shows early signs of efficacy.

  7. Blueprint For Early Phase Clinical Pharmacology Studies In Dermatology 4/11/2025

    Explore the landscape of dermatological drug development through a comprehensive framework for rational early-phase dermatological trials, centered around five foundational pillars.

  8. A Smartphone Based Biomarker For The Estimation Of Unipolar Depression Severity 3/28/2025

    The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.

  9. Remote Patient Monitoring Using Mobile Health Technology 3/28/2025

    This study investigates the attitudes of cancer patients towards the adoption of mHealth technologies, including applications and wearable devices, for monitoring purposes during or after their treatment.